We present a case report of transient fetal anhydramnios following maternal non-steroidal anti-inflammatory drug use in pregnancy. This reduction in liquor volume resolved following cessation of the medication with no obvious ill-effect on neonatal outcome. The case report is followed by a comprehensive summary of the relevant literature.
SinghG. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatis and Aging Medical Information System. Am J Ther2000; 7: 115–121.
2.
Nezvalova-HenriksenKSpigsetONordengH. Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study. BJOG2013; 120: 948–959.
3.
OstensenM. Drugs in pregnancy. Rheumatological disorders. Best Pract Res Clin Obstet Gynaecolg2001; 15: 953–969.
4.
LoeSMSanchez-RamosLKaunitzAM. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol2005; 106: 173–179.
5.
GroomKMShennanAHJonesBA. TOCOX: a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. BJOG2005; 112: 725–730.
6.
CuzzolinL. Drug-related perinatal damage from the pharmacological point of view. J Pediatr Neonat Individual Med2014; 3: e030253–e030253.
7.
Abou-GhannamGUstaIMNassarAH. Indomethacin in pregnancy: applications and safety. Am J Perinatol2012; 29: 175–186.
8.
AntonucciRZaffanelloMPuxedduE. Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab2012; 13: 474–490.
9.
CantorBTylerTNelsonRM. Oligohydramnios and transient neonatal anuria: a possible association with maternal use of prostaglandin synthetase inhibitors. J Reprod Med1980; 24: 220–223.
10.
ShenORabinowitzRLavieO. Good fetal outcome following prolonged indomethacin induced anhydramnios. J Perinat Med1995; 23: 233–236.
11.
HickockDEHollenbachKAReilleySF. The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol1989; 160: 1525–1530.
12.
TopuzSHasRErmisH. Acute severe reversible oligohydramnios induced by indomethacin in a patient with rheumatoid arthritis: a case report and review of the literature. Clin Exp Obstet Gynecol2004; 31: 70–72.
13.
FieniSGramelliniDVadoraE. Oligohydramnios and fetal renal sonographic appearances related to prostaglandin synthetase inhibitors. A case report. Fetal Diagn Ther2004; 19: 224–227.
14.
PomeranzAKorzetsZDolfinZ. Acute renal failure in the neonate induced by the administration of indomethacin as a tocolytic agent. Nephrol Dial Transplant1996; 11: 1139–1141.
15.
AlessandriJLAbossoloTReynaudI. Non-steroidal anti-inflammatory agents and pregnancy. A study of renal and digestive toxicity of niflumic acid in the perinatal period. J Gynecol Obstet Biol Reprod1994; 23: 813–818.
16.
PhadkeVBhardwajSSahooB. Maternal ingestion of diclofenac leading to renal failure in newborns. Pediatr Nephrol2012; 27: 1033–1036.
17.
Van der HeijdenBJCarlusCNarcyF. Persistent anuria, neonatal death and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol1994; 171: 617–623.
18.
CuzzolinLFanosVPinnaB. Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol2006; 21: 931–938.
19.
SandruckJCGrobmanWAGerberSE. The effect of short-term indomethacin therapy on amniotic fluid volume. Am J Obstet Gynaecol2005; 192: 1443–1445.
20.
LocatelliAVerganiPBelliniP. Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin. BJOG2001; 108: 325–326.
21.
NortonMEMerrillJCooperBA. Neonatal complications after the administration of indomethacin for preterm labor. New Engl J Med1993; 329: 1602–1607.
22.
SavageNHAndersonBLSimhanHN. The safety of prolonged indomethacin therapy. Am J Perinatol2007; 24: 207–213.
